662 related articles for article (PubMed ID: 29904379)
1. Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials.
Flórez-Grau G; Zubizarreta I; Cabezón R; Villoslada P; Benitez-Ribas D
Front Immunol; 2018; 9():1169. PubMed ID: 29904379
[TBL] [Abstract][Full Text] [Related]
2. Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial.
Zubizarreta I; Flórez-Grau G; Vila G; Cabezón R; España C; Andorra M; Saiz A; Llufriu S; Sepulveda M; Sola-Valls N; Martinez-Lapiscina EH; Pulido-Valdeolivas I; Casanova B; Martinez Gines M; Tellez N; Oreja-Guevara C; Español M; Trias E; Cid J; Juan M; Lozano M; Blanco Y; Steinman L; Benitez-Ribas D; Villoslada P
Proc Natl Acad Sci U S A; 2019 Apr; 116(17):8463-8470. PubMed ID: 30962374
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of tolerogenic dendritic cells in IBD: from animal models to clinical application.
Cabezón R; Benítez-Ribas D
Clin Dev Immunol; 2013; 2013():789814. PubMed ID: 24319468
[TBL] [Abstract][Full Text] [Related]
4. Recent discoveries in dendritic cell tolerance-inducing pharmacological molecules.
Švajger U; Rožman PJ
Int Immunopharmacol; 2020 Apr; 81():106275. PubMed ID: 32044665
[TBL] [Abstract][Full Text] [Related]
5. Tolerogenic Immunotherapy: Targeting DC Surface Receptors to Induce Antigen-Specific Tolerance.
Castenmiller C; Keumatio-Doungtsop BC; van Ree R; de Jong EC; van Kooyk Y
Front Immunol; 2021; 12():643240. PubMed ID: 33679806
[TBL] [Abstract][Full Text] [Related]
6. Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses.
Schülke S
Front Immunol; 2018; 9():455. PubMed ID: 29616018
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells in central nervous system autoimmunity.
Sie C; Korn T
Semin Immunopathol; 2017 Feb; 39(2):99-111. PubMed ID: 27888330
[TBL] [Abstract][Full Text] [Related]
8. Regulatory dendritic cells in autoimmunity: A comprehensive review.
Liu J; Cao X
J Autoimmun; 2015 Sep; 63():1-12. PubMed ID: 26255250
[TBL] [Abstract][Full Text] [Related]
9. Generation of immunogenic and tolerogenic clinical-grade dendritic cells.
Kalantari T; Kamali-Sarvestani E; Ciric B; Karimi MH; Kalantari M; Faridar A; Xu H; Rostami A
Immunol Res; 2011 Dec; 51(2-3):153-60. PubMed ID: 22105838
[TBL] [Abstract][Full Text] [Related]
10. Increased T-cell immunity against aquaporin-4 and proteolipid protein in neuromyelitis optica.
Matsuya N; Komori M; Nomura K; Nakane S; Fukudome T; Goto H; Shiraishi H; Wandinger KP; Matsuo H; Kondo T
Int Immunol; 2011 Sep; 23(9):565-73. PubMed ID: 21795759
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with autologous dendritic cells: from experimental autoimmune encephalomyelitis to multiple sclerosis.
Link H; Huang YM; Masterman T; Xiao BG
J Neuroimmunol; 2001 Mar; 114(1-2):1-7. PubMed ID: 11240009
[TBL] [Abstract][Full Text] [Related]
12. Tolerogenic dendritic cells: key regulators of peripheral tolerance in health and disease.
Saei A; Hadjati J
Int Arch Allergy Immunol; 2013; 161(4):293-303. PubMed ID: 23689518
[TBL] [Abstract][Full Text] [Related]
13. The Importance of Dendritic Cells in Maintaining Immune Tolerance.
Audiger C; Rahman MJ; Yun TJ; Tarbell KV; Lesage S
J Immunol; 2017 Mar; 198(6):2223-2231. PubMed ID: 28264998
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cells from bench to bedside and back.
Adema GJ
Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells in multiple sclerosis: key players in the immunopathogenesis, key players for new cellular immunotherapies?
Nuyts AH; Lee WP; Bashir-Dar R; Berneman ZN; Cools N
Mult Scler; 2013 Jul; 19(8):995-1002. PubMed ID: 23369893
[TBL] [Abstract][Full Text] [Related]
16. Dendritic Cells As Inducers of Peripheral Tolerance.
Iberg CA; Jones A; Hawiger D
Trends Immunol; 2017 Nov; 38(11):793-804. PubMed ID: 28826942
[TBL] [Abstract][Full Text] [Related]
17. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
18. Antigen-specific immunotherapy via delivery of tolerogenic dendritic cells for multiple sclerosis.
Li V; Binder MD; Purcell AW; Kilpatrick TJ
J Neuroimmunol; 2024 May; 390():578347. PubMed ID: 38663308
[TBL] [Abstract][Full Text] [Related]
19. Induction of anergic and regulatory T cells by plasmacytoid dendritic cells and other dendritic cell subsets.
Kuwana M
Hum Immunol; 2002 Dec; 63(12):1156-63. PubMed ID: 12480259
[TBL] [Abstract][Full Text] [Related]
20. The spectrum of neuromyelitis optica.
Wingerchuk DM; Lennon VA; Lucchinetti CF; Pittock SJ; Weinshenker BG
Lancet Neurol; 2007 Sep; 6(9):805-15. PubMed ID: 17706564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
